About
Technology
Issues
FAQ
Links
Official Page
Safety, efficacy and immunogenicity of switching from innovator to biosimilar infliximab in patients with spondyloarthritis: a 6-month real-life observational study
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.